Propel Bio Management, LLC has filed its 13F form on February 14, 2025 for Q4 2024 where it was disclosed a total value porftolio of $101 Billion distributed in 21 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Plains Gp Holdings LP with a value of $23.4B, Madrigal Pharmaceuticals, Inc. with a value of $13.3B, Akero Therapeutics, Inc. with a value of $9.56B, Achieve Life Sciences Inc with a value of $8.63B, and Applied Therapeutics Inc. with a value of $8.23B.

Examining the 13F form we can see an decrease of $71.7B in the current position value, from $172B to 101B.

Propel Bio Management, LLC is based out at Los Angeles, CA

Below you can find more details about Propel Bio Management, LLC portfolio as well as his latest detailed transactions.

Portfolio value $101 Billion
Healthcare: $67.4 Billion
Energy: $23.4 Billion

Stock Holdings Table Market Cap. of $2 Billions to $10 Billions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 21
  • Current Value $101 Billion
  • Prior Value $172 Billion
  • Filing
  • Period Q4 2024
  • Filing Date February 14, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 2 stocks
  • Additional Purchases 4 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 2 stocks
Track This Portfolio

Track Propel Bio Management, LLC Portfolio

Follow Propel Bio Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Propel Bio Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Propel Bio Management, LLC with notifications on news.